Shuttle-Mediated Drug Delivery to the Brain

被引：70

作者：

Malakoutikhah, Morteza ^{[1
]}

Teixido, Meritxell ^{[1
]}

Giralt, Ernest ^{[1
,2
]}

机构：

[1] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain

[2] Univ Barcelona, Dept Organ Chem, Barcelona, Spain

来源：

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2011年 / 50卷 / 35期

关键词：

blood-brain barrier; brain uptake; drug delivery; peptides; shuttle-mediated delivery; 80-COATED POLYBUTYLCYANOACRYLATE NANOPARTICLES; CENTRAL-NERVOUS-SYSTEM; CONJUGATED PEGYLATED NANOPARTICLES; BARRIER IN-VIVO; TARGETED DELIVERY; MONOCLONAL-ANTIBODY; ALZHEIMERS-DISEASE; FUSION PROTEIN; PHARMACOLOGICAL-ACTIVITY; TRANSFERRIN-RECEPTOR;

D O I：

10.1002/anie.201006565

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Advances in the field of shuttle-mediated drug delivery have been made in the last decade; however, the treatment of brain disorders still remains a great challenge because of the presence of the blood-brain barrier (BBB), a structure that limits the access of drugs to their site of action in the central nervous system. Several strategies have been proposed to enhance the transport of drugs across the BBB. In this Review, we focus on the vector-mediated approach, in which a drug is coupled to a molecule (shuttle) that has the ability to cross the BBB and deliver the drug to the brain. © 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

引用

页码：7998 / 8014

页数：17

共 131 条

[1] Transporting therapeutics across the blood-brain barrier [J].

Abbott, NJ ;

Romero, IA .

MOLECULAR MEDICINE TODAY, 1996, 2 (03) :106-113

[2] Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes [J].

Afergan, Eyal ;

Epstein, Hila ;

Dahan, Rachel ;

Koroukhov, Nickolay ;

Rohekar, Keren ;

Danenberg, Haim D. ;

Golomb, Gershon .

JOURNAL OF CONTROLLED RELEASE, 2008, 132 (02) :84-90

[3] Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26 [J].

Aktas, Y ;

Yemisci, M ;

Andrieux, K ;

Gürsoy, RN ;

Alonso, MJ ;

Fernandez-Megia, E ;

Novoa-Carballal, R ;

Quiñoá, E ;

Riguera, R ;

Sargon, MF ;

Çelik, HH ;

Demir, AS ;

Hincal, AA ;

Dalkara, T ;

Çapan, Y ;

Couvreur, P .

BIOCONJUGATE CHEMISTRY, 2005, 16 (06) :1503-1511

[4] Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery [J].

Alavijeh M.S. ;

Chishty M. ;

Qaiser M.Z. ;

Palmer A.M. .

NeuroRX, 2005, 2 (4) :554-571

[5] Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles [J].

Alyautdin, RN ;

Petrov, VE ;

Langer, K ;

Berthold, A ;

Kharkevich, DA ;

Kreuter, J .

PHARMACEUTICAL RESEARCH, 1997, 14 (03) :325-328

[6] Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study [J].

Alyautdin, RN ;

Tezikov, EB ;

Ramge, P ;

Kharkevich, DA ;

Begley, DJ ;

Kreuter, J .

JOURNAL OF MICROENCAPSULATION, 1998, 15 (01) :67-74

[7] Dependence of nelfinavir brain uptake on dose and tissue concentrations of the selective P-glycoprotein inhibitor zosuquidar in rats [J].

Anderson, BD ;

May, MJ ;

Jordan, S ;

Song, L ;

Roberts, MJ ;

Leggas, M .

DRUG METABOLISM AND DISPOSITION, 2006, 34 (04) :653-659

[8]

ANDERSON WR, 1987, PSYCHOPHARMACOLOGY, V92, P157

[9]

Banks WA, 1998, J CELL SCI, V111, P533

[10] HIV-1 protein gp120 crosses the blood-brain barrier: Role of adsorptive endocytosis [J].

Banks, WA ;

Kastin, AJ ;

Akerstrom, V .

LIFE SCIENCES, 1997, 61 (09) :PL119-PL125

← 1 2 3 4 5 6 7 8 9 10 →